Abcellera Biologics shares owned by Raymond James & Associates
Quarter-by-quarter ownership of Abcellera Biologics (ABCL) shares owned by Raymond James & Associates
from 13F filings
Historical chart of Raymond James & Associates investment in Abcellera Biologics
Tip: Access up to 7 years of quarterly data
All positions including Abcellera Biologics held by Raymond James & Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Abcellera Biologics by Raymond James & Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $62k | 14k | 4.53 |
| 2023-12-31 | $71k | 12k | 5.71 |
| 2023-09-30 | $74k | 16k | 4.60 |
| 2023-06-30 | $341k | 53k | 6.46 |
| 2023-03-31 | $355k | 47k | 7.54 |
| 2022-12-31 | $207k | 20k | 10.13 |
| 2022-09-30 | $222k | 23k | 9.88 |
| 2022-06-30 | $194k | 18k | 10.67 |
| 2022-03-31 | $156k | 16k | 9.75 |
| 2021-12-31 | $1.0M | 73k | 14.30 |
| 2021-09-30 | $2.5M | 126k | 20.04 |
| 2021-06-30 | $2.6M | 119k | 22.00 |
| 2021-03-31 | $2.5M | 73k | 33.97 |
More positions owned by Raymond James & Associates
Home Depot (HD)
View all positions for Raymond James & Associates